Thursday, 17 March 2016

Stock Cash Premium: Sun Pharma's arm Taro plans shares repurchase worth US$ 250mn

For Stock Cash Premium

Taro Pharmaceutical Industries reportedly said that its board of directors has approved a $250-mn share repurchase of its ordinary shares.

Repurchases may be made from time to time at the company's discretion, based on ongoing assessments of the capital needs of the business, the market price of its stock, and general market conditions, the company reportedly said.

Sun Pharmaceuticals Industries Ltd ended at Rs. 836.65, down by Rs. 7.25 or 0.86% from its previous closing of Rs. 843.9 on the BSE.

The stock traded below its 200 DMA.


  1. Latest news, updates of Share market and tips on your mobile,just subscribe Epic Research to get many more.

  2. Rudra investment Market Expert gives the best service of Profitable Stock Tips. Rudra Investment aim to make people invest their money into Indian stock market with the minimum risk and earn maximum money.It Is a Best SEBI Registered Company in India.